Weight Management Supplements: Which Ones Actually Work – Agape Nutrition
Left Continue shopping
Your Order

You have no items in your cart

Water, oats, legumes, and a blank supplement bottle for an evidence guide to weight management supplements

Weight Management Supplements: What Actually Has Evidence

Here is the honest answer before anything else: no dietary supplement in this aisle works like a GLP-1 prescription medication, and no reputable trial we reviewed claims otherwise. That does not make the entire category noise, though. A few ingredients have genuine, human, randomized-trial evidence behind them, and a couple, protein above all, do something most diet pills cannot: they help you hold on to muscle while the weight comes off. This guide grades the most talked-about weight management supplements against a single number, the 2.5 kilogram clinical-relevance threshold, so you can tell which ones are worth your money and which ones are not.

Table of Contents

The 2.5 kg rule: how to grade any weight management supplement

Most weight-management supplement marketing lives in adjectives. The science lives in one uncomfortable number.

In 2021, researchers pooled 67 randomized, placebo-controlled trials covering the isolated compounds sold for weight management (Bessell 2021) [1]. Three ingredients came out with a statistically significant weight difference versus placebo:

  • Chitosan: -1.84 kg (95% CI -2.79 to -0.88)
  • Glucomannan: -1.27 kg (95% CI -2.45 to -0.09)
  • Conjugated linoleic acid (CLA): -1.08 kg (95% CI -1.61 to -0.55)

Those are the best results in the entire category, and every one of them lands short of the bar that matters. Fructans, another fiber family, had no meaningful effect at all (p=0.24).

The yardstick: researchers generally accept 2.5 kg as the minimum weight difference that counts as clinically relevant. Across 67 randomized trials, not one supplement cleared it.

That 2.5 kg threshold is the whole story of this aisle.

Use 2.5 kg as your default filter. If a product cannot point to an effect that approaches it, treat its larger claims with skepticism. From here, we grade each ingredient against that number.

Bar chart comparing weight management supplements to the 2.5 kg clinical relevance threshold
Every ingredient in this guide, ranked against the 2.5 kg clinical-relevance threshold. None of them clear it.

The evidence-graded ingredient table

This table is the spine of the article: dose studied, effect size in kilograms where one exists, and a plain verdict.

Ingredient Dose studied Effect size Verdict
Green tea catechins (with caffeine) Varied by trial -1.38 kg body weight (95% CI -1.70 to -1.06) vs caffeine Real but small; only works with caffeine
High protein under energy restriction Higher-protein vs standard diets -0.79 kg weight; -0.87 kg fat mass; +0.43 kg fat-free mass Best body-composition signal in the category
Whey protein during a deficit 27 g/day Muscle protein synthesis fell 9% (vs 28% soy, 31% carb) Protects muscle protein synthesis
Berberine Dose-response, varied -0.29 kg/m² BMI; -2.75 cm waist; -0.11 kg weight (not significant) Mixed; moved BMI and waist, not scale weight
Glucomannan (konjac fiber) Varied -0.79 kg (one meta) vs -0.22 kg not significant (another) Weak and inconsistent
Conjugated linoleic acid (CLA) 3.2 g/day (median) About 0.05 kg/week fat loss; -1.08 kg pooled Tiny, measurable, isomer-dependent
Chromium picolinate 200 to 1,000 µg/day -1.1 kg (95% CI -1.8 to -0.4) Rests on one trial; low-quality evidence
MCT oil Substituted for dietary fat -0.67 kg upper-body adipose over 28 days Modest signal, not a weight-loss tool

A few notes to read alongside the table, because a bare number can mislead.

The biggest kilogram figure belongs to green tea catechins with caffeine, and even its own authors call the reduction "modest at best." The most important row is not the biggest number. It is the high-protein row, because protein is the only intervention here that preserves muscle instead of just nudging the scale. Several of these effects are not on scale weight at all, which matters when you are deciding what "works" means. Chitosan, which posted the largest single effect in the pooled analysis at -1.84 kg, is listed in the pooled-analysis results above.

Metabolism support supplements: small, real signals

Products marketed as metabolism support supplements get sold as if they raise your energy burn. The evidence is a good deal narrower than that.

Green tea catechins (the strongest evidence, with a catch)

Green tea catechins, the polyphenols behind EGCG, hold the most plentiful and consistent clinical evidence in the category. One meta-analysis of 15 randomized trials and 1,243 people (Phung 2010) [2] found that catechins taken with caffeine reduced:

  • Body weight by -1.38 kg (95% CI -1.70 to -1.06) versus caffeine alone
  • BMI by -0.55 (95% CI -0.65 to -0.40)
  • Waist circumference by -1.93 cm (95% CI -2.82 to -1.04)

The catch is that none of this shows up without caffeine. Against a caffeine-free control, the effect shrank to -0.44 kg, and catechins without caffeine showed no benefit on any endpoint. The authors' own words: "the clinical significance of these reductions is modest at best."

So green tea gives a small, caffeine-dependent nudge toward a healthy metabolism. The catechins on their own are not carrying the load. If you would rather supplement than brew it, XYMOGEN Green Tea 600 is a water-extracted green tea formula built around its catechins.

MCT oil (a body-composition signal, not a shortcut)

Medium-chain triglycerides show up in a lot of metabolic formulas. A 28-day trial in men with a BMI of 25 to 31 (St-Onge 2003) [3] found MCT cut upper-body adipose tissue by -0.67 ± 0.26 kg versus -0.02 ± 0.19 kg on olive oil, a statistically significant difference (p<0.05). Energy expenditure ticked up slightly across the trial.

The honest caveat: the same research group's separate 27-day trial found increased fat oxidation and energy expenditure with no change in body composition at all. The signal is real but modest and mixed. MCT is a reasonable fat swap for some people.

Berberine (real, small, and it needs a safety note)

A dose-response meta-analysis of 10 studies (Xiong 2020) [4] found berberine moved BMI by -0.29 kg/m² (95% CI -0.51 to -0.08, p=0.006) and waist circumference by -2.75 cm (95% CI -4.88 to -0.62, p=0.01). But it did not move scale weight: -0.11 kg (95% CI -0.99 to 0.76, p=0.79), which is not significant. A newer 2026 pooled analysis (Elahi Vahed 2026) [5] also exists, though its abstract was not available for this review, so its specific findings are not cited here.

Mandatory safety note before anyone rushes toward berberine. Berberine can cause gastrointestinal side effects, and it inhibits the CYP3A4 and CYP2D6 liver enzymes, which metabolize a large share of prescription drugs [25]. A clinical review of herb-drug interaction studies found that inhibition to be weak at commonly recommended doses, but the authors still advise caution [26]. Check with your clinician before combining berberine with anything you already take. For the full evidence breakdown on this ingredient, read our dedicated berberine guide.

Appetite support supplements: weak and inconsistent

Appetite support supplements aim at the drive to eat. Most of them have thin, conflicting evidence behind them.

Glucomannan (konjac fiber): two meta-analyses that disagree

Glucomannan is a water-soluble fiber that swells in the stomach. Two meta-analyses reached opposite verdicts, and you deserve both:

  • Positive: 14 studies and 531 people (Sood 2008) [6] found body weight fell -0.79 kg (95% CI -1.53 to -0.05).
  • Null: 9 trials (Onakpoya 2014) [7] found -0.22 kg (95% CI -0.62 to 0.19), not statistically significant.

Reported side effects include abdominal discomfort, diarrhea, and constipation. One caution reviewers note: glucomannan is taken with water as a fiber matrix, so part of the measured change may reflect that water and fiber load rather than a metabolic effect.

Honest verdict: small, inconsistent, and not the satiety hero its marketing suggests. If you want fiber for satiety, you want it from food, covered below, not from a capsule.

Chromium picolinate: an effect resting on one trial

Chromium rides a reputation for supporting healthy blood sugar, and steady blood sugar can matter for appetite. The weight evidence is fragile. One meta-analysis of 10 trials and 489 people (Pittler 2003) [8] reported -1.1 kg (95% CI -1.8 to -0.4). A sensitivity analysis dropped that to -0.9 kg and made it statistically non-significant, which the authors said left the effect "largely dependent on the results of a single trial."

A Cochrane review (Tian 2013) [9] found a similar -1.1 kg but graded it low quality, with no dose gradient across 200 to 1,000 µg and serious adverse events reported at 1,000 µg. Two independent reviews converge on, in the Cochrane authors' words, "no current, reliable evidence to inform firm decisions." Blood-sugar support is a separate conversation we cover in our metabolic syndrome and insulin resistance guide. The trials used chromium picolinate specifically, and Pure Encapsulations Chromium (Picolinate) 500 mcg sits inside the 200 to 1,000 mcg range those trials studied.

Conjugated linoleic acid (CLA): tiny, measurable, isomer-dependent

CLA is a fatty acid found in meat and dairy, and the results depend heavily on which isomer you take. Across 18 studies at a median dose of 3.2 g/day (Whigham 2007) [10], CLA produced fat loss of roughly 0.05 ± 0.05 kg per week. That is real, and it is also very small. Pooled across everything (Bessell 2021) [1], CLA lands at -1.08 kg.

Verdict: measurable, modest, and not a reason to choose a product by itself.

Protein and fiber for satiety: the two that move body composition

Here the aisle stops being noise. Protein and fiber do not work by speeding up your metabolism. They work through satiety and through protecting lean tissue, and that is the mechanism with the strongest data in the entire category.

High protein under energy restriction (the body-composition win)

A meta-analysis of 24 randomized trials and 1,063 people (Wycherley 2012) [11] compared higher-protein to standard-protein diets at matched calories. Over a mean of 12.1 weeks, the higher-protein arm showed:

  • Body weight: -0.79 kg (95% CI -1.50 to -0.08)
  • Fat mass: -0.87 kg (95% CI -1.26 to -0.48)
  • Fat-free mass: +0.43 kg preserved (95% CI 0.09 to 0.78)
  • Resting energy expenditure: +595.5 kJ/day (95% CI 67.0 to 1,124.1)

That preserved fat-free mass is the headline, and it is the only such signal on this list. Greater satiety showed in three of five studies that measured it. Protein does not act on fat directly. It supports the two things that actually change body composition: appetite regulation and lean mass.

Whey protein during a deficit (protecting muscle protein synthesis)

When you run a calorie deficit, your body gets more willing to break down muscle for fuel. A tightly controlled study put people through a 750 kcal-per-day deficit for two weeks and compared 27 g of whey, 26 g of soy, and 25 g of carbohydrate (Hector 2015) [12]. Muscle protein synthesis fell 9 ± 1% on whey, versus 28 ± 5% on soy and 31 ± 5% on carbohydrate.

Whey cut the drop in muscle protein synthesis by roughly two thirds compared to soy, and by even more against carbohydrate. This is why a protein target, rather than a fat burner, is the most defensible supplement decision in a weight-management plan.

Weight management supplements and GLP-1 care: lean mass lost vs protein and resistance training
The GLP-1 question is really a muscle question. These are the two levers with real evidence behind them.

Fiber and satiety, honestly framed

Fiber matters for satiety, but the mechanism rarely gets stated straight. Soluble and fermentable fibers feed gut bacteria, and those bacteria produce signals, including the gut hormones GLP-1 and PYY, that help you feel full. That is real physiology, and it is worth acting on.

The honesty part: the strongest direct evidence for this chain is mechanistic, and much of it comes from animals. A rat study (Zhou 2008) [13] showed resistant starch upregulating GLP-1 and PYY in a sustained, day-long way. Reviews on inulin and oligofructose (Delzenne 2005) [14] sit solidly in mechanism territory. A 2026 review (Wang 2026) [15] connects dietary fiber to GLP-1 physiology, again as physiology rather than as a clinical claim.

The honest sentence is: fiber supports the gut environment and the satiety signals your body already makes; it does not raise GLP-1 like a drug. Anyone who tells you otherwise is overselling. Vegetables, legumes, and other fiber-forward foods are the cheapest version of this benefit, and they deliver satiety without the capsule markup. For more on how the gut handles what you feed it, see our guide to digestive support.

What does not work

Some of this aisle has been tested and failed. Stating it plainly is the fastest way to save you money.

Garcinia cambogia (HCA): failed the definitive trial

Garcinia cambogia, the hydroxycitric acid that dominated 2010s weight-loss marketing, had its definitive test back in 1998 in JAMA (Heymsfield 1998) [16]. In a 12-week randomized, double-blind, placebo-controlled trial of 135 people taking 1,500 mg of HCA per day, the active group lost 3.2 ± 3.3 kg and the placebo group lost 4.1 ± 3.9 kg.

The placebo arm lost more, and the difference was not significant (P=0.14). There was no difference in fat-mass loss either. The authors' conclusion is blunt: the compound "failed to produce significant weight loss and fat mass loss beyond placebo."

Raspberry ketone: no human trial of the ingredient alone

Raspberry ketone survives on borrowed credibility. There is no human trial of the ingredient by itself. The most-cited animal study (Cotten 2017) [17] found it "has limited benefit to adipose loss beyond reducing energy intake" in mice, meaning the mice ate less; they did not burn more.

The one human trial (Arent 2018) [18] used a multi-ingredient blend of raspberry ketone, capsaicin, caffeine, garlic, and Citrus aurantium, so it cannot isolate raspberry ketone. Both groups lost weight because both groups dieted and exercised. A blend that hides behind caffeine plus a diet program is not evidence for raspberry ketone. A case report has also linked a raspberry ketone weight-loss supplement to coronary vasospasm [19].

BCAA supplements for muscle preservation: explicitly failed

Branched-chain amino acids get sold hard for protecting muscle during a cut. The trial that matters (Ooi 2021) [20] ran 132 adults through a 500 kcal-per-day deficit for 16 weeks. BCAA supplementation, in the authors' words, "does not preserve lean mass or affect insulin sensitivity," and a higher-protein diet may be more advantageous.

The amino-acid aisle cannot do what whole protein does. This is a useful counterpoint when you are choosing between a BCAA tub and a whey shake.

The GLP-1 era: keeping muscle while the weight comes off

This is where the real anxiety in the category lives now. Readers are not trying to lose 20 pounds with a pill. They are trying to hold onto muscle while a GLP-1 medication takes the weight off, and they want to know whether any supplement helps.

The concern is legitimate. Across a systematic review of semaglutide trials covering 1,541 patients in 6 trials [21], lean mass accounted for anywhere from almost 0% to 40% of total weight reduction.

On a rapid weight trajectory, up to two fifths of what you lose can be lean tissue, not fat.

What does the evidence say moves the needle against that?

  • Higher protein is associated with preserved lean tissue. A secondary analysis of 191 older adults (mean age 65.1, mean BMI 32.9) found higher protein intake was significantly associated with increased appendicular lean soft tissue (beta = 1.0, p = 0.047), with no effect on weight or fat (Eglseer 2026) [22].
  • Whey specifically protected muscle protein synthesis during a deficit in the Hector study above [12].
  • Resistance training is the other lever, and it has the strongest track record for preserving muscle in this context.

An important piece of honesty. The trial that will directly test resistance training plus protein during GLP-1 therapy, the LEAN-PREP trial (Alawadhi 2026) [23], is a protocol, not a result. It randomizes 232 adults to resistance exercise, protein, both, or control, with a protein target of 1.6 g/kg per day and an MRI measure of quadriceps muscle at six months. It has no results yet, so do not let anyone cite it as proof of an outcome.

What you can act on now: aim for protein around 1.6 g of protein per kilogram of body weight per day, and add resistance training two to three times a week (the LEAN-PREP protocol tests three sessions a week). Those two interventions are the ones with genuine, muscle-specific evidence, and they are yours to adjust. For a longer look at why muscle matters over time, read our guide to muscle mass as you age.

How to read a GLP-1 support label: weight management supplements checklist with four quality checks
Four checks that separate a real formula from marketing. If a label fails any of them, walk away.

How to read a GLP-1 support label

The "GLP-1 support" shelf is where most of the overreach lives, and it is also where adulteration has been found. Here is a short checklist for any product that claims to support GLP-1 or weight management.

  1. Does it disclose every ingredient and every dose? A proprietary blend that lists ingredients without amounts hides the exact thing that decides whether the product can work. Skip it, or find one that shows the numbers.
  2. Does it claim to match a drug? No dietary supplement replaces or acts like semaglutide or tirzepatide. Any equivalence language is a red flag, full stop.
  3. Is there human trial data for the ingredient itself, at a meaningful dose? If the only study is in mice, or in a multi-ingredient blend that masks the doses, treat the claim as unproven.
  4. Has it been tested for what is actually inside? Independent testing has found commercial diet products containing undeclared drugs, including sibutramine, fluoxetine, and DNP, plus contaminants such as heavy metals and molds (ConsumerLab) [24]. Weight-management products carry a real adulteration risk most other supplement categories do not.
  5. Do the side effects get disclosed honestly? Hoodia, another once-hyped appetite ingredient, had clinical data showing no weight-loss benefit paired with adverse reactions [24].

Your fastest filter is the ingredient-and-dose line on the back of the label. If you cannot read exactly what is in the product and how much, assume the marketing is doing the work. For a full walkthrough of what a quality supplement label should contain, see our guide to reading a supplement label.

The honest bottom line

Let me close the loop on the 2.5 kg rule. Across 67 randomized trials, the best supplements in this aisle landed between roughly 1 kg and 1.8 kg, and none cleared the 2.5 kg bar that counts as clinically relevant. Green tea catechins work, but only with caffeine, and modestly. Glucomannan, chromium, and CLA are small and inconsistent. Berberine shows real but mixed signals, with a mandatory interaction warning attached.

The two things that demonstrably move body composition are protein and resistance training. Protein supports appetite regulation and preserves lean mass. Resistance training builds the muscle you are trying to keep. Supplements, at best, support those two levers.

The aisle's real value, and the reason a curated, practitioner-grade retailer like Agape Nutrition exists, is quality and label integrity: ingredients you can verify on the label, at real doses, from a catalog that is screened rather than swept off a shelf. That philosophy is the through-line of our Weight & Metabolism hub.

Most of this aisle is noise. A small part of it helps at the margins. And the part that matters most does not come in a capsule at all.

What We Recommend

Nothing here clears the 2.5 kg bar, and none of it replaces the two levers that actually move body composition: a protein target and resistance training. What follows is the short list from our catalog that matches the evidence above.

References

  1. Bessell E, Maunder A, Lauche R, Adams J, Sainsbury A, Fuller NR. Efficacy of dietary supplements containing isolated organic compounds for weight loss: a systematic review and meta-analysis of randomised placebo-controlled trials. Int J Obes (Lond). 2021. https://pubmed.ncbi.nlm.nih.gov/33976376/
  2. Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr. 2010 Jan;91(1):73-81. https://pubmed.ncbi.nlm.nih.gov/19906797/
  3. St-Onge MP, Ross R, Parsons WD, Jones PJ. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res. 2003 Mar;11(3):395-402. https://pubmed.ncbi.nlm.nih.gov/12634436/
  4. Xiong P, Niu L, Talaei S, et al. The effect of berberine supplementation on obesity indices: A dose-response meta-analysis and systematic review of randomized trials. Complement Ther Clin Pract. 2020 May;39:101113. https://pubmed.ncbi.nlm.nih.gov/32379652/
  5. Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026. https://pubmed.ncbi.nlm.nih.gov/41310257/
  6. Sood N, Baker WL, Coleman CI. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr. 2008 Oct;88(4):1167-75. https://pubmed.ncbi.nlm.nih.gov/18842808/
  7. Onakpoya I, Posadzki P, Ernst E. The efficacy of glucomannan supplementation in overweight and obesity: a systematic review and meta-analysis of randomized clinical trials. J Am Coll Nutr. 2014;33(1):70-8. https://pubmed.ncbi.nlm.nih.gov/24533610/
  8. Pittler MH, Stevinson C, Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int J Obes Relat Metab Disord. 2003 Apr;27(4):522-9. https://pubmed.ncbi.nlm.nih.gov/12664086/
  9. Tian H, Guo X, Wang X, He Z, Sun R, Ge S, Zhang Z. Chromium picolinate supplementation for overweight or obese adults. Cochrane Database Syst Rev. 2013 Nov 29;2013(11):CD010063. https://pubmed.ncbi.nlm.nih.gov/24293292/
  10. Whigham LD, Watras AC, Schoeller DA. Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr. 2007 May;85(5):1203-11. https://pubmed.ncbi.nlm.nih.gov/17490954/
  11. Wycherley TP, Moran LJ, Clifton PM, Noakes M, Brinkworth GD. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012 Dec;96(6):1281-98. https://pubmed.ncbi.nlm.nih.gov/23097268/
  12. Hector AJ, Marcotte GR, Churchward-Venne TA, et al. Whey protein supplementation preserves postprandial myofibrillar protein synthesis during short-term energy restriction in overweight and obese adults. J Nutr. 2015. https://pubmed.ncbi.nlm.nih.gov/25644344/
  13. Zhou J, Martin RJ, Tulley RT, et al. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rats. Am J Physiol Endocrinol Metab. 2008. https://pubmed.ncbi.nlm.nih.gov/18796545/
  14. Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr. 2005. https://pubmed.ncbi.nlm.nih.gov/15877889/
  15. Wang Y, Liu J, Verbeke K, Retamal NG, Akkerman R, de Vos P. Dietary Fiber and Glucagon-Like Peptide-1 Receptor Agonists in Obesity Management. Adv Nutr. 2026. https://pubmed.ncbi.nlm.nih.gov/42106160/
  16. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998 Nov 11;280(18):1596-600. https://pubmed.ncbi.nlm.nih.gov/9820262/
  17. Cotten BM, Diamond SA, Banh T, et al. Raspberry ketone fails to reduce adiposity beyond decreasing food intake in C57BL/6 mice fed a high-fat diet. Food Funct. 2017 Apr 19;8(4):1512-1518. https://pubmed.ncbi.nlm.nih.gov/28378858/
  18. Arent SM, Walker AJ, Pellegrino JK, et al. The Combined Effects of Exercise, Diet, and a Multi-Ingredient Dietary Supplement on Body Composition and Adipokine Changes in Overweight Adults. J Am Coll Nutr. 2018 Feb;37(2):111-120. https://pubmed.ncbi.nlm.nih.gov/29111889/
  19. Coronary vasospasm and raspberry ketones weight-loss supplement: Is there a connection? https://pubmed.ncbi.nlm.nih.gov/32870171/
  20. Ooi DSQ, Ling JQR, Sadananthan SA, et al. Branched-Chain Amino Acid Supplementation Does Not Preserve Lean Mass or Affect Metabolic Profile in Adults with Overweight or Obesity. J Nutr. 2021 Apr 8;151(4):911-920. https://pubmed.ncbi.nlm.nih.gov/33537760/
  21. Systematic review of the effect of semaglutide on lean mass: insights from clinical trials. https://pubmed.ncbi.nlm.nih.gov/38629387/
  22. Eglseer D, Reiter L, Schoufour JD, et al. Higher protein intake and appendicular lean soft tissue in older adults with overweight or obesity. Nutr J. 2026 Jan 22;25(1):24. https://pubmed.ncbi.nlm.nih.gov/41572290/
  23. Alawadhi AA, Alroudhan D, Alsaeed DJ, et al. LEAN mass Preservation with Resistance Exercise and Protein during semaglutide and tirzepatide therapy (LEAN-PREP): a randomized trial protocol. BMJ Open. 2026 Apr 22;16(4):e116911. https://pubmed.ncbi.nlm.nih.gov/42020128/
  24. ConsumerLab.com. Weight Loss Supplements Review. https://www.consumerlab.com/reviews/weight-loss-supplements/
  25. Bathaei P, Imenshahidi M, Hosseinzadeh H. Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review. Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):179-202. https://pubmed.ncbi.nlm.nih.gov/39141022/
  26. Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med. 2012 Sep;78(13):1458-77. https://pubmed.ncbi.nlm.nih.gov/22855269/

Frequently asked questions

Do GLP-1 support supplements work like a prescription GLP-1 drug?

No. No dietary supplement matches the effect of semaglutide or tirzepatide, and no reputable trial claims otherwise. A few ingredients can support the satiety signals your body already makes, at a much smaller scale. Be wary of drug-equivalence language.

Is "nature's Ozempic" real?

It is a marketing phrase, not a science finding. The ingredients grouped under that label, berberine most often, have real but small trial data, and none approaches a drug effect. Treat the phrase as a red flag.

Does berberine work for weight management?

The pooled data is mixed. Across 10 studies, berberine moved BMI by -0.29 kg/m² and waist by -2.75 cm, but not scale weight (-0.11 kg, not significant) [4]. It also carries gastrointestinal side effects and inhibits CYP3A4 and CYP2D6, the enzymes that clear many prescription drugs [25], so it deserves a clinician's input.

How much green tea extract should I take?

The trials that showed an effect used catechins combined with caffeine, and even then the reduction was modest, -1.38 kg [2]. Catechins without caffeine showed no benefit. Expect a small, caffeine-dependent nudge, not a measurable transformation.

Does fiber actually help with weight management?

Fiber supports satiety by feeding the gut bacteria that produce fullness signals like GLP-1 and PYY. The direct evidence is mostly mechanistic and partly from animal studies [13][14]. Frame it as "fiber supports the satiety system you already have," not "fiber raises GLP-1 like a drug."

Will I lose muscle on a GLP-1 medication?

It is a real risk. Across semaglutide trials, lean mass has accounted for up to 40% of total weight lost [21]. The two evidence-backed defenses are protein around 1.6 g/kg per day and resistance training. The ongoing LEAN-PREP trial is testing this, with no results yet [23].

What can I actually take that does something?

Protein, first. Higher daily protein preserved fat-free mass and improved satiety in pooled trials [11], and whey protected muscle protein synthesis during a deficit [12]. Everything else is marginal. Green tea catechins with caffeine [2], and to a smaller extent MCT [3] and CLA [10], show small signals.

Are weight management pills safe? What is actually in them?

This is the wrong category for blind trust. Independent testing has found undeclared drugs, including sibutramine, fluoxetine, and DNP, in commercial diet products [24]. Read the ingredient-and-dose line on the label, and skip proprietary blends that hide the amounts.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.